Searched for
EMROK 0
Cipla, PAG eye Wockhardt’s formulations businessWockhardt employs more than 7,000 people and has a presence in the US, Britain, Ireland, Switzerland, France, Mexico, Russia and other coun...- Wockhardt back in the black, posts Q3 profit of Rs 19 croreWockhardt had posted a net loss of Rs 76.86 crore for the corresponding period of 2018-19.
- Wockhardt gets DGCI approval for 2 new antibiotics"DCGI (Drug Controller General of India) has approved Wockhardt's two new antibiotics, EMROK (IV) and EMROK 0 (Oral), for acute bacterial s...
- Load More